Efficacy of Single- and Dual-Docking Robotic Surgery of Paraaortic and Pelvic Lymphadenectomy in High-Risk Endometrial Cancer

Overview

Journal J Pers Med

Date 2024 May 25

PMID 38793024

Authors

Magdalena Bizon

Maciej Olszewski

Agnieszka Grabowska

Joanna Siudek

Krzysztof Mawlichanow

Radovan Pilka

Affiliations

Soon will be listed here.

Abstract

(1) The surgical method of choice for the treatment of endometrial cancer is minimally invasive surgery. In cases of high-risk endometrial cancer, completed paraaortic and pelvic lymphadenectomy are indicated. The aim of this study was to analyze the types of docking during robotic surgery assisted with the da Vinci X system while performing paraaortic and pelvic lymphadenectomy. (2) Methods: A total of 25 patients with high-risk endometrial cancer, with a mean age of 60.07 ± 10.67 (range 34.69-83.23) years, and with a mean body mass index (BMI) of 28.4 ± 5.62 (range 18-41.5) kg/m, were included in this study. The analyzed population was divided into groups that underwent single or dual docking during surgery. (3) Results: No statistical significance was observed between single and dual docking during paraaortic and pelvic lymphadenectomy and between the type of docking and the duration of the operation. However, there was a statistically significant correlation between the duration of the operation and previous surgery ( < 0.005). The number of removed lymph nodes was statistically associated with BMI ( < 0.005): 15.87 ± 6.83 and 24.5 ± 8.7 for paraaortic and pelvic lymph nodes, respectively, in cases of single docking, and 18.05 ± 7.92 and 24.88 ± 11.75 for paraaortic and pelvic lymph nodes, respectively, in cases of dual docking. (4) Conclusions: The robot-assisted approach is a good surgical method for lymphadenectomy for obese patients, and, despite the type of docking, there are no differences in the quality of surgery.

References

Aalders J, Thomas G . Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol. 2006; 104(1):222-31. DOI: 10.1016/j.ygyno.2006.10.013. View

AlHilli M, Mariani A . The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol. 2013; 18(2):193-9. DOI: 10.1007/s10147-013-0528-7. View

Li Z, Zhang W, Luo Z, Huang J, Li L . Clinical study of the clinical characteristics and prognosis of 1219 cases of endometrial cancer with lymph node metastasis. Hum Exp Toxicol. 2021; 40(10):1601-1611. DOI: 10.1177/09603271211008506. View

Papathemelis T, Scharl S, Kronberger K, Gerken M, Scharl A, Pauer A . Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis. J Cancer Res Clin Oncol. 2017; 143(12):2555-2562. DOI: 10.1007/s00432-017-2508-1. View

Fisher B . The revolution in breast cancer surgery: science or anecdotalism?. World J Surg. 1985; 9(5):655-66. DOI: 10.1007/BF01655177. View

LEWIS Jr G, Bundy B . Surgery for endometrial cancer. Cancer. 1981; 48(2 Suppl):568-74. DOI: 10.1002/1097-0142(19810715)48:1+<568::aid-cncr2820481321>3.0.co;2-2. View

Dowdy S, Aletti G, Cliby W, Podratz K, Mariani A . Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol. 2008; 111(3):418-24. PMC: 2727450. DOI: 10.1016/j.ygyno.2008.08.021. View

Mariani A, Dowdy S, Cliby W, Gostout B, Jones M, Wilson T . Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008; 109(1):11-8. PMC: 3667391. DOI: 10.1016/j.ygyno.2008.01.023. View

Kitchener H, Swart A, Qian Q, Amos C, Parmar M . Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2008; 373(9658):125-36. PMC: 2646126. DOI: 10.1016/S0140-6736(08)61766-3. View

10.

Abu-Rustum N, Chi D, Leitao M, Oke E, Hensley M, Alektiar K . What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?. Gynecol Oncol. 2008; 111(1):46-8. DOI: 10.1016/j.ygyno.2008.06.010. View

11.

Bakkum-Gamez J, Mariani A, Dowdy S, Weaver A, McGree M, Cliby W . The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol. 2011; 123(1):58-64. DOI: 10.1016/j.ygyno.2011.06.018. View

12.

Geppert B, Persson J . Robotic infrarenal paraaortic and pelvic nodal staging for endometrial cancer: feasibility and lymphatic complications. Acta Obstet Gynecol Scand. 2015; 94(10):1074-81. DOI: 10.1111/aogs.12712. View

13.

Todo Y, Suzuki Y, Azuma M, Hatanaka Y, Konno Y, Watari H . Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report. Gynecol Oncol. 2012; 127(3):532-7. DOI: 10.1016/j.ygyno.2012.08.026. View

14.

Creasman W, Morrow C, Bundy B, Homesley H, Graham J, Heller P . Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987; 60(8 Suppl):2035-41. DOI: 10.1002/1097-0142(19901015)60:8+<2035::aid-cncr2820601515>3.0.co;2-8. View

15.

Watari H, Katayama H, Shibata T, Ushijima K, Satoh T, Onda T . Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3). Jpn J Clin Oncol. 2017; 47(10):986-990. DOI: 10.1093/jjco/hyx108. View

16.

Persson J, Salehi S, Bollino M, Lonnerfors C, Falconer H, Geppert B . Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer. 2019; 116:77-85. DOI: 10.1016/j.ejca.2019.04.025. View

17.

Soliman P, Frumovitz M, Spannuth W, Greer M, Sharma S, Schmeler K . Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010; 119(2):291-4. PMC: 4264592. DOI: 10.1016/j.ygyno.2010.07.011. View

18.

Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N . Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010; 375(9721):1165-72. DOI: 10.1016/S0140-6736(09)62002-X. View

19.

Marek R, Dzvincuk P, Hambalek J, Maderka M, Jancekova V, Kolarova V . Robotic paraaortic lymphadenectomy in oncogynecology. Double side docking of daVinci S system increases the success rates of high paraaortic lymph node dissection in endometrial cancer. Ceska Gynekol. 2019; 84(1):4-17. View

20.

Kodama S, Kase H, Tanaka K, Matsui K . Multivariate analysis of prognostic factors in patients with endometrial cancer. Int J Gynaecol Obstet. 1996; 53(1):23-30. View